Introduction
In a recent survey, Candida spp. were the fourth most common organism causing hospital-based bloodstream infections, surpassed only by Staphylococcus and Enterococcus species [1] . While Candida albicans remains the species most frequently isolated, the incidence of Candida glabrata infections have been increasing steadily so that it is now the second most commonly isolated Candida species in the United States [2 -4] . Although considered a commensal of the human epithelia, C. glabrata is capable of causing serious systemic infections in susceptible hosts. It has been shown to have reduced susceptibility to azole drugs, which may be a contributing factor to the increased proportion of infections caused by this species during the recent era of antifungal drug use [5, 6] .
We recently performed MLST analysis in order to genotype C. glabrata bloodstream isolates collected from the Atlanta, GA area in 2008 -2010 [9] . MLST allows highly reproducible strain discrimination, as well as the development of genotypic strain archives that can be stored digitally for both prospective and retrospective analysis [10, 11] . We showed for Atlanta, GA, that the bloodstream isolates were composed of a relatively few sequence types (STs), and was dominated by STs (ST16 and ST3) that had increased from 22% of the population in 1992 -1993 to 60% of the population in 2008 -2009 [9] . This suggested the question of whether these sequence types were more abundant in candidemia cases because they were more prominent in the population of all circulating C. glabrata strains in hospitalized patients in Atlanta or whether those STs had some intrinsic quality that made them more effective at causing candidemia. To test this hypothesis, a second set of non-invasive C. glabrata isolates collected in an Atlanta area hospital during the same time period was also analyzed by MLST to determine the relatedness of those isolates to those recovered from bloodstream infections. In addition, antifungal susceptibility testing was performed to assess the role of antifungal drug resistance as a contributing factor in the population structure or strain abundance in either of the two populations.
Materials and methods

Isolates
In this study 90 incident C. glabrata bloodstream isolates from an ongoing, population-based surveillance (2008 -2010) in metro Atlanta were tested of which 62 of these have been previously characterized [9] . In addition, 111 isolates from non-sterile body-sites (referred to as noninvasive in this manuscript) were selected at random from a collection maintained by a metro Atlanta hospital participating in the Atlanta candidemia surveillance. These were selected so that: (i) there was only one isolate per patient, (ii) isolates were collected during 2007 -2008, (iii) patients did not have any indication of C. glabrata candidiasis including localized or deep-seeded infection during their hospital stay (isolates were from sputum, stool, or urine) and (iv) there was no known epidemiologic relationship among patients. Prior to their use all isolates were stored in glycerol at Ϫ 70 ° C. Isolates were identifi ed as C. glabrata by conventional biochemical means and by Luminex assay for bloodstream isolates [12] . The fi nal identity of all isolates was confi rmed by positive MLST analysis. The closely related species Candida nivariensis and Candida bracarensis were ruled out by a lack of amplifi cation with the MLST primer set [9] .
DNA extraction, PCR amplifi cation and sequencing
After two passages of each isolate on Sabouraud dextrose agar plates, DNA was extracted using the Mo Bio Microbial DNA Isolation kit (Mo Bio Laboratories, Inc., Carlsbad, CA, USA) according to the manufacturer ' s instructions. The six oligonucleotide primer sets used for MLST analysis were those described by Dodgson et al . [13] . PCR reactions were performed exactly as discussed previously from our laboratory [9] . PCR products were purifi ed using Exo SAP-IT as described by the manufacturer (USB, Cleveland, OH, USA). Sequencing reactions were performed using BigDye terminator technology (ABI, Foster City, CA, USA) with an ABI Prism 3730 DNA sequencer. All loci were sequenced in both forward and reverse directions with the same primers as those used for the PCR reactions.
Antifungal susceptibility testing
C. glabrata antifungal susceptibility testing was performed by broth microdilution using fl uconazole, voriconazole, posaconazole, and caspofungin as described by Clinical Laboratory Standards Institute (CLSI) M27-A3 document guidelines [14] using RPMI microbroth trays custom manufactured by TREK Diagnostics (Cleveland, OH, USA). Amphotericin B MIC values were determined by Etest (Biomerieux, Inc, Durham, NC, USA). All results were read visually after 24 h of incubation for the echinocandins and after 48 h for the azoles and amphotericin B.
Data analysis
Nucleotide sequences were determined by alignment of the forward and reverse sequences with Sequencher ™ 4.7 software (Genecodes Inc., Ann Arbor, MI, USA), and polymorphisms were confi rmed by visual examination of the sequence traces. Sequences were then compared to the C. glabrata MLST database (http://cglabrata.mlst.net) to assign allele numbers and sequence types. All new alleles were submitted to the C. glabrata database curator for inclusion in the database. Population analysis was performed using the GENALEX 6 software environment [15] for principal coordinate analysis, Nei ' s genetic distance and genetic identity, and for analysis of molecular variance. F ST values were calculated using Popgene (v1.31) [16] .
Results
A total of 90 Candida glabrata bloodstream isolates collected in 2008 -2009 in Atlanta, GA were analyzed by MLST [9] . In addition, we studied 111 non-invasive be different, the arbitrarily-assigned ST numbers do not refl ect the allelic diversity or identity within populations. A genetic distance value of 0, or a genetic identity value of 1, indicates that the populations share all of the alleles, as well as the allelic frequencies. For the candidemia and non-invasive populations, we calculated values of 0.137 for genetic distance and 0.872 for genetic identity which suggests that the two populations are very similar and that they share both alleles and allele frequencies. Wright ' s fi xation index (F ST ) is a measure of genetic divergence among populations at individual loci. A value of 0 indicates no genetic divergence between the populations, while 1 indicates fi xation of alleles in divergent populations. An F ST value of Ͼ 0.15 is generally used to indicate signifi cant differentiation between two populations. An analysis of allelic similarity between the candidemia and non-invasive populations gave an F ST value of 0.010, again indicating very little differentiation between the two populations and a general lack of alleles fi xed in one population or the other.
Analysis of molecular variance (AMOVA) is another method for partitioning diversity within and between populations. AMOVA analysis revealed that 97% of the variance occurred within each population while only 3% of the variance occurred between the two populations. We used the AMOVA genetic distance matrix to perform principal coordinate analysis (PCA) between the two populations. PCA is a multivariate analysis that allows the two dimensional visualization of the major components of variation between complex data sets and is plotted according to population. Fig. 2 shows that although there is some separation of the candidemia and non-invasive populations, the two populations had generally overlapping distributions, and that in general the division by principal components of variation was again within the two populations and not between the two populations.
isolates collected in the same time period from one of the Atlanta surveillance institutions. MLST typing of the noninvasive isolates revealed one ST that had been recently described in a Maryland population [9] but not in Atlanta, and two new STs. The fi rst was the result of a novel combination of existing alleles and was represented twice in the non-invasive isolate population. The second was a result of novel alleles at NMT1 , UGP1 , and TRP1 . The NMT1 and UGP1 loci displayed new alleles as the result of new combinations of existing SNPs. In addition to a new combination of existing SNPs, TRP1 had a new mutation at position 210 consisting of a G → A non-synonomous 1st position transversion (ala → thr). There was equal ST diversity in the candidemia and non-invasive populations with 16 different STs in each population (Fig. 1) . Both populations had exclusive STs, i.e., 8% of the candidemia STs were not found in the non-invasive population and 10% of the non-invasive STs were not found in the candidemia population. Three major sequence types (ST16, ST3 and ST19) predominated in the candidemia population, and together comprised 64% of this population (Table 1) , while the same three STs represented 43% of the noninvasive population. Although ST8, ST10 and ST15 comprised another 39% of the non-invasive isolates, they were only 18% of the candidemia isolates. Together these six sequence types accounted for 82% of each of the two populations, with other unique STs comprising the other 18%. There were three statistically signifi cant differences in the percentage of isolates in each population, i.e., the proportion of ST16 in the candidemia population ( P ϭ 0.024) and the proportions of ST8 ( P ϭ 0.024) and ST15 ( P ϭ 0.03) in the non-invasive population (Fisher ' s exact test).
Nei ' s genetic distance and Nei ' s genetic identity values are used to measure the differences in frequencies of alleles among the two populations. Although the STs may 
Antifungal susceptibility of candidemia and non-invasive isolates
Fluconazole resistance (MIC Ն 64 μ g/ml) was shown in 22 isolates in the total collection and they were evenly distributed, with 11 each in the candidemia and non-invasive populations (Table 2 ). These resistant isolates were distributed among nine STs, mostly in ST3 or ST16 ( n ϭ 12), although this distribution was not statistically signifi cant. Twentyfi ve isolates were voriconazole resistant or susceptibledose dependent (MIC Ն 2 μ g/ml) with 15 in the candidemia population and 10 in the non-invasive population. Fifteen of the voriconazole resistant isolates were ST3 or ST16, and this distribution was statistically signifi cant ( P ϭ 0.05). The voriconazole geometric mean MIC values for the candidemia and non-invasive populations were the same, but the MIC distributions were different. Both populations had an MIC 50 of 0.5 μ g/ml but the MIC 90 of the non-invasive isolates was 1 μ g/ml and the MIC 90 of the candidemia isolates was 4 μ g/ml. This difference was statistically signifi cant ( P ϭ 0.02).
Only fi ve isolates in the total population had elevated caspofungin MIC values (MIC Ն 0.5 μ g/ml). All of these isolates were in the candidemia population and they were distributed among four of the major STs. The only other signifi cant difference in the MIC distributions between candidemia and non-invasive isolates was for amphotericin B. However, since all isolates were well within the range considered clinically susceptible (MIC Յ 1 μ g/ml), this difference is probably not clinically relevant.
Discussion
Candida glabrata has long been recognized as a human commensal, and colonization has been shown to increase as a function of host age [17] . Its increasing importance as an opportunist in immunocompromised individuals receiving prophylaxis has been well documented [2, 18] , particularly because of its innate ability to acquire antifungal resistance [19, 20] . Little is known about the epidemiology of Candida glabrata , particularly the degree of genetic relatedness between bloodstream isolates and non-invasive isolates. An assessment of this relationship could help address the question of whether every Candida glabrata isolate is capable of becoming a successful pathogen, or whether pathogenicity is limited to specifi c genetic lineages that disproportionately undergo clonal expansion. In order to address this question, we previously assessed the ST distribution of a population of bloodstream isolates from the Atlanta, GA metropolitan area. We determined that ST3, ST16 and ST19 were the major sequence types recovered from candidemia isolates in Atlanta [9] . In this study, we added ST data from isolates from the same geographic region and time period that were known not to be causing invasive disease. We found that non-invasive populations of C. glabrata are also enriched in the same three STs (ST3, ST16, and ST19), and that the isolates from the candidemia and non-invasive collections had very similar population structure. Although a combination of the genotypes ST16, ST3 and ST19 were predominate in both populations (43% of the non-invasive population and 64% of the candidemia population), ST16 was signifi cantly enriched in the candidemia population. In a recent study, Enache-Angoulvant et al . [21] showed through microsatellite typing that there were more unique genotypes among digestive tract isolates than among bloodstream isolates in their European C. glabrata populations. Their study was limited by the fact that their two populations were not temporally and geographically linked. We found that the diversity was similar between the two groups with each group having 16 STs in total and six unique STs. Most C. glabrata fungemias are thought to originate from the endogenous fl ora of the host [19, 22] , suggesting that in order to predominate as a pathogen, an isolate must fi rst predominate as a commensal. Due to their relative abundance in the population, ST3, ST16, and ST19 may be more available when host factors or environmental conditions allow them to switch from a commensal state to a pathogenic state. Yet there is also some evidence that certain STs may be better pathogens. While we found that the percentage of the population comprised of ST3, ST16 and ST19 increased from commensalism to infection, the opposite was true for the other three abundant STs in our population. While ST8, ST10 and ST15 formed a major proportion of the non-invasive population (39%), these same STs formed a much smaller percentage of the candidemia population (18%). Although the six most prevalent STs (see Table 1 ) comprise the same proportion of isolates in the candidemia and non-invasive isolates, the STs are not equally distributed between the two groups. In the noninvasive population ST8, ST10 and ST15 are more prevalent and at least for ST8 and ST15 this difference is statistically signifi cant. This may indicate that ST8, ST10 and ST15 are less fi t as pathogens than as commensals.
However, ST10 was the third most prevalent ST from candidemia isolates in Baltimore [9] . This shift in population structure between commensalism and infection may be indicative of the fi tness of certain sequence types for one or the other role.
Antifungal resistance does not seem to play a role in determining the population structure of either the candidemia or non-invasive populations. It had been previously shown that there was no difference in susceptibility to antifungal drugs between candidemia and colonizing isolates of C. glabrata in three hospitals in New York [23] . We similarly found no signifi cant association between fl uconazole resistance from either the candidemia or non-invasive population, nor did we fi nd an association between fl uconazole resistance and any of the major sequence types that comprise the majority of isolates within either population. This indicates that selection through antifungal resistance does not account for the increase in specifi c STs, but it does not mean that the enriched STs may not have a growth advantage under antifungal pressure, as this parameter could not be measured in this study. There were statistically signifi cant differences associated with voriconazole resistance. It is puzzling as to why such association between voriconazole and either population would have occurred, since voriconazole is not one of the major antifungal drugs used to treat candidemia patients in Atlanta [A. Ahlquist and S. Lockhart, unpublished] . Voriconazole, a more potent azole, may exert more selective pressure than fl uconazole.
Antifungal susceptibility and selection pressure has long been considered a driver for the increase in C. glabrata incidence in the US. Eleven percent of the C. glabrata isolates in this study were fl uconazole resistant. This percentage is similar to that reported for C. glabrata in the US since at least the late 1990s [6, 24] , but has not been dramatically increasing as much as the prevalence of C. glabrata BSI has been increasing. We have documented an increase over time in the prevalence of the major C. glabrata STs (ST3, ST16 and ST19) in US populations [9] . One intriguing aspect of this increase is that the most prevalent sequence type in both candidemia and non-invasive populations is ST16, a ST that is exclusively found in the US [13, 25, 26] . At the same time, C. glabrata comprises a much smaller percentage of bloodstream isolates recovered from other countries around the world [24,27 -31] . Perhaps the clonal expansion of a small set of STs has contributed to the increase in prevalence of C. glabrata in the US through enhanced commensalism.
There are several limitations to our study. The fi rst is that we have treated the candidemia and non-invasive populations as geographically equivalent when that is not necessarily the case. While the candidemia isolates came from a collection of 20 hospitals within our catchment area, the non-invasive isolates came from a single hospital within Voriconazole Ն 2 μ g/ml b
Sequence type Candidemia Non-invasive Candidemia Non-invasive (12) 11 (9) 15 (17) 10 (9) a Resistant isolates only; b Resistant and susceptible-dose dependent isolates.
that same area. It is not clear whether collecting non-invasive isolates from a broader swath of our catchment area would change the overall genetic diversity of that population or reveal signifi cant differences in diversity. Furthermore, it is not clear to what extent the non-invasive collection refl ects the actual numbers of isolates collected in this institution, whereas the bloodstream collection was collected through audited surveillance and is highly refl ective of the full diversity of the bloodstream population. Second, our conclusion that there is no signifi cant association between sequence type and fl uconazole resistance made the assumption that our genetic markers can be in some way genetically linked to markers directly associated with fl uconazole resistance and that the linkage can be measured by our parameters but this is not necessarily the case. For some strains, antifungal resistance may be more epigenetic in nature and not associated with a specifi c mutation [32] . This epigenetic tendency would not necessarily be measurable in our assay, especially in isolates from patients not previously exposed to fl uconazole. Another possibility is that the gene(s) for fl uconazole resistance, such as effl ux pumps, etc. [22] , are located on chromosomes not associated with MLST markers or distally located such that linkage cannot be detected. Studies are ongoing to determine if surrogate markers can be developed for azole resistance and incorporated into an MLST typing scheme.
Third, MLST is of very low discriminatory power for distinguishing C. glabrata strains, so the isolates within any one subgroup may be more diverse than we can measure.
